Study on the Pharmacokinetics and Relative Bioavailability of Irbesartan Orally Disintegrating Tablets in Healthy Volunteers

Jin You,Luo Xiang,Zhou J,Long Lihong,Chen Jianguo
DOI: https://doi.org/10.3969/j.issn.1008-049X.2008.02.010
2008-01-01
Abstract:Objective:To study the pharmacokinetics and relative bioavailability of irbesartan orally disintegrating tablets in 20 healthy volunteers.Method:According to a randomized two-period crossover design,20 healthy volunteers were orally administered with 300 mg irbesartan orally disintegrating tablets or common irbesartan tablets,respectively.Irbesartan in plasma was determined by HPLC with valsartan used as internal standard,and the data were processed with 3P97 pharmacokinetic program.Result:The pharma- cokinetic parameters of the two tabletes were as follows:AUC_(0-36h)were(18.2±4.9)μg·ml~(-1).h and(17.2±4.1)μg·ml~(-1). h,C_(max)were(2.8±0.6)μg·ml~(-1)and(2.8±0.7)μg·ml~(-1),T_(max)were(1.6±0.4)h and(1.5±0.4)h,respectively.Con- clusion:The concentration-time curves of two tablets can be discribed with a two-compartment model,and the differences of their main pharmacokinetic parameters were not statistically significant(P>0.05).Compared with reference formulations,the relative bioavail- ability of the test is 95.8%±13.9%,then the test and reference formulations are bioequivalent.
What problem does this paper attempt to address?